Kensey Nash News

The tender offer is being made in connection with the Agreement and Plan of Merger, dated as of 2 May 2012, by and among DSM, Biomedical Acquisition Corporation and Kensey Nash, which DSM and Kensey Nash announced on 3 May 2012.

Complete terms and conditions of the tender offer are set forth in the Offer to Purchase, Letter of Transmittal and other related materials that will be filed by DSM and Biomedical Acquisition Corporation with the SEC on 21 May 2012.

An investigation on behalf of investors in NASDAQ:KNSY shares concerning whether the offer by Royal DSM to take over Kensey Nash Corporation at $38.50 per share and the takeover process are unfair to investors in Kensey Nash was announced.

New York, NY - May 4, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Thursday, May 03.

It may sound good to be one of the day's hottest stocks on the New York Stock Exchange or Nasdaq.

Green Mountain Coffee Roasters Inc. : After Green Mountain lowered its FY12 adjusted EPS guidance, Roth Capital believes that the company continues to generate strong growth.

Shares of the following companies are having unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 10:50 a.m. in New York.

BG Group A has agreed to sell its 60.1% stake in Brazilian gas distribution companyA ComgA s A toA Cosan S.A. IndAostria e ComA©rcio A for approximately $1.8 billion.A www.bg-group.com IBM has agreed to acquire Tealeaf , a San Franciscobased provider of online customer experience management solutions.

* Offer price represents 33% premium to Kensey Nash's closing share price on May 2, 2012 * Kensey Nash Board of Directors unanimously recommends the offer * Kensey Nash is a leader in regenerative medicine and biomaterials R&D, with world class manufacturing and strong strategic partnerships * Strong strategic fit; acquisition will strengthen and ... (more)

Dutch food and chemicals group DSM said on Thursday it has agreed to acquire U.S. medical device-maker Kensey Nash Corp for about $335 million in an all-cash deal aimed at strengthening its biomedical business.